Federated Hermes’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-92
Closed -$1.7K 2067
2025
Q1
$1.7K Sell
92
-16
-15% -$289 ﹤0.01% 1962
2024
Q4
$1.78K Hold
108
﹤0.01% 1983
2024
Q3
$1.51K Buy
+108
New +$1.2K ﹤0.01% 1951
2022
Q1
Sell
-37,739
Closed -$354K 2191
2021
Q4
$354K Sell
37,739
-64,074
-63% -$769K ﹤0.01% 1550
2021
Q3
$1.61M Sell
101,813
-24,271
-19% -$436K ﹤0.01% 1110
2021
Q2
$2.73M Hold
126,084
0.01% 1003
2021
Q1
$2.55M Buy
126,084
+125,941
+88,071% +$2.49M 0.01% 1032
2020
Q4
$3K Sell
143
-31,570
-100% -$464K ﹤0.01% 2084
2020
Q3
$369K Sell
31,713
-322,424
-91% -$3.74M ﹤0.01% 1549
2020
Q2
$3.27M Buy
+354,137
New +$3.17M 0.01% 831
2018
Q3
Sell
-75
Closed -$4K 2253
2018
Q2
$4K Sell
75
-237
-76% -$10.4K ﹤0.01% 2033
2018
Q1
$11K Buy
+312
New +$9.57K ﹤0.01% 1862

Other funds holding AXGN

Federated Hermes's AXGN Position: Q2 2025 in Review

Federated Hermes sold out of Axogen (AXGN) in Q2 2025, closing a stake of 92 shares — an estimated $1.7K sold.

Federated Hermes first reported a position in AXGN in Q1 2018 and held it in 12 quarters. The position peaked at $3.27M in Q2 2020. 155 funds tracked by Wall St. Rank hold AXGN as of Q2 2025.

  • Federated Hermes reported no remaining Axogen position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 92 Axogen shares in Q2 2025, an estimated $1.7K.
  • Federated Hermes first reported a position in Axogen in Q1 2018 and held it in 12 quarters.
  • Federated Hermes's Axogen position peaked at $3.27M in Q2 2020.
  • 155 funds tracked by Wall St. Rank held Axogen as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.